Amarogentin | CAS 21018-84-8 - Request Quote
Amarogentin
| SZ CAT No: | SZ-M161601 |
| CAS No | 21018-84-8 |
| Mol.F. | C29H30O13 |
| Mol.Wt. | 586.5 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Amarogentin is chemically (2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-(((4aS,5R,6S)-1-oxo-5-vinyl-4,4a,5,6-tetrahydro-1H,3H-pyrano[3,4-c]pyran-6-yl)oxy)tetrahydro-2H-pyran-3-yl 3,3',5-trihydroxy-[1,1'-biphenyl]-2-carboxylate. Amarogentin is supplied with detailed characterization data compliant with regulatory guideline. Amarogentin can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Miscellaneous-2.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 21018-84-8
Purchase 21018-84-8
Order 21018-84-8
Enquire 21018-84-8
price of 21018-84-8
21018-84-8 Supplier
21018-84-8 Manufacturer
21018-84-8 Exporter
buy high quality Amarogentin
Purchase Amarogentin
Amarogentin suppliers
Amarogentin manufacturers
Amarogentin price
Order Amarogentin
Enquire Amarogentin
Amarogentin cost
Amarogentin Supplier
Amarogentin Distributor
Amarogentin for Method Validation
Miscellaneous-2 Reference Standard
Amarogentin for ANDA Filing
Amarogentin for Forced Degradation Studies
Amarogentin Identification Standards
Amarogentin for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


